Ginsburg D - Search Results

1

Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro.

Eitzman DT, Fay WP, Lawrence DA, Francis-Chmura AM, Shore JD, Olson ST, Ginsburg D. Eitzman DT, et al. Among authors: ginsburg d. J Clin Invest. 1995 May;95(5):2416-20. doi: 10.1172/JCI117937. J Clin Invest. 1995. PMID: 7738206 Free PMC article.

2

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation.

Fay WP, Shapiro AD, Shih JL, Schleef RR, Ginsburg D. Fay WP, et al. Among authors: ginsburg d. N Engl J Med. 1992 Dec 10;327(24):1729-33. doi: 10.1056/NEJM199212103272406. N Engl J Med. 1992. PMID: 1435917 Free article. No abstract available.

3

Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center.

Sherman PM, Lawrence DA, Yang AY, Vandenberg ET, Paielli D, Olson ST, Shore JD, Ginsburg D. Sherman PM, et al. Among authors: ginsburg d. J Biol Chem. 1992 Apr 15;267(11):7588-95. J Biol Chem. 1992. PMID: 1559996 Free article.

4

The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain.

Cooney KA, Nichols WC, Bruck ME, Bahou WF, Shapiro AD, Bowie EJ, Gralnick HR, Ginsburg D. Cooney KA, et al. Among authors: ginsburg d. J Clin Invest. 1991 Apr;87(4):1227-33. doi: 10.1172/JCI115123. J Clin Invest. 1991. PMID: 1672694 Free PMC article.

5

A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide.

Bahou WF, Ginsburg D, Sikkink R, Litwiller R, Fass DN. Bahou WF, et al. Among authors: ginsburg d. J Clin Invest. 1989 Jul;84(1):56-61. doi: 10.1172/JCI114169. J Clin Invest. 1989. PMID: 2472430 Free PMC article.

6

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.

Ginsburg D, Zeheb R, Yang AY, Rafferty UM, Andreasen PA, Nielsen L, Dano K, Lebo RV, Gelehrter TD. Ginsburg D, et al. J Clin Invest. 1986 Dec;78(6):1673-80. doi: 10.1172/JCI112761. J Clin Invest. 1986. PMID: 3097076 Free PMC article.

7

The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.

Konkle BA, Ginsburg D. Konkle BA, et al. Among authors: ginsburg d. J Clin Invest. 1988 Aug;82(2):579-85. doi: 10.1172/JCI113635. J Clin Invest. 1988. PMID: 3136192 Free PMC article.

8

Localization of vitronectin binding domain in plasminogen activator inhibitor-1.

Lawrence DA, Berkenpas MB, Palaniappan S, Ginsburg D. Lawrence DA, et al. Among authors: ginsburg d. J Biol Chem. 1994 May 27;269(21):15223-8. J Biol Chem. 1994. PMID: 7515053 Free article.

9

Serpin-protease complexes are trapped as stable acyl-enzyme intermediates.

Lawrence DA, Ginsburg D, Day DE, Berkenpas MB, Verhamme IM, Kvassman JO, Shore JD. Lawrence DA, et al. Among authors: ginsburg d. J Biol Chem. 1995 Oct 27;270(43):25309-12. doi: 10.1074/jbc.270.43.25309. J Biol Chem. 1995. PMID: 7592687 Free article.

10

Molecular evolution of plasminogen activator inhibitor-1 functional stability.

Berkenpas MB, Lawrence DA, Ginsburg D. Berkenpas MB, et al. Among authors: ginsburg d. EMBO J. 1995 Jul 3;14(13):2969-77. doi: 10.1002/j.1460-2075.1995.tb07299.x. EMBO J. 1995. PMID: 7621813 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters